ライフサイエンスコーパス: decanoate

1 spective inducers: salicylate, paraquat, and decanoate.

2 e as to effective dose ranges of haloperidol decanoate.

3 heifers (n = 5) treated with nortestosterone decanoate (0.85 mg/kg body weight), untreated heifers (n

4 d was decreased for those taking haloperidol decanoate (-0.96 kg; 95% CI, -1.88 to -0.04).

5 NMR solution structures of spinach ACP with decanoate (10:0-ACP) and stearate (18:0-ACP) attached to

6 ns included double-blinded weekly nandrolone decanoate (100 mg for women; 200 mg for men) or placebo

7 orbol ester derivative, 4alpha-phorbol 12,13-decanoate (100 nm), induces modest channel activation, w

8 Nandrolone decanoate, 100 mg (n = 14), or placebo (n = 15) by intra

9 -methylbutyl acetate, ethyl octanoate, ethyl decanoate, 2-phenylethyl acetate, 2-phenylethanol, 2-met

10 Intramuscular injections of haloperidol decanoate 25 to 200 mg or paliperidone palmitate 39 to 2

11 e stabilized with a low dose of fluphenazine decanoate (5 to 10 mg every 14 days), which was suppleme

12 peridone palmitate compared with haloperidol decanoate (adjusted hazard ratio, 0.98; 95% CI, 0.65-1.4

13 creased by the addition of ethyl-octanoate, -decanoate and -dodecanoate, but decreased by ethyl-hexan

14 e data showed that only two variables (ethyl decanoate and ethyl acetate) were necessary for a succes

15 ers (terpenyl esters, ethyl octanoate, ethyl decanoate and hexyl acetate) and alcohols (1-nonanol and

16 Nandrolone decanoate and resistance exercise produced anabolic effe

17 at the induction of the AcrAB efflux pump by decanoate and the more lipophilic unconjugated bile salt

18 to four different fixed doses of haloperidol decanoate and treated for 1 year or until relapse.

19 Decanoate and unconjugated bile salts, which are present

20 of capsinoids (vanillyl caprylate, vanillyl decanoate and vanillyl laurate) was obtained.

21 tepulciano wines were ethyl hexanoate, ethyl decanoate, and ethyl octanoate, whereas phenyl ethanol a

22 rval between injections during intramuscular decanoate antipsychotic treatment.

23 ugh unexpectedly, it was mildly repressed by decanoate by an unknown mechanism.

24 The increasingly lipophilic octanoate (C8), decanoate (C10) and dodecanoate (C12) derivatives were e

25 whether long-term treatment with haloperidol decanoate contributes to altered GAD67 mRNA expression.

26 use of paliperidone palmitate vs haloperidol decanoate did not result in a statistically significant

27 Intramuscular injections of compound 41 (the decanoate ester of racemate 32) eliminated cocaine-maint

28 mentation of the growth media with exogenous decanoate fatty acid, suggesting a compensatory mechanis

29 zed on a maintenance regimen of fluphenazine decanoate for a mean of 16.7 months had their antipsycho

30 operon improved the MIC of exogenously added decanoate for an acrAB mutant strain.

31 tosterone, methandrostenolone, or nandrolone decanoate) for 6 weeks.

32 p gained weight and those in the haloperidol decanoate group lost weight; after 6 months, the least-s

33 tate group and 47 (32.4%) in the haloperidol decanoate group.

34 ng male sexual behavior patterns (nandrolone decanoate > methandrostenolone > 17 alpha-methyltestoste

35 Patients taking haloperidol decanoate had significantly larger increases in global r

36 Patients who received nandrolone decanoate increased their LBM by 3.1 +/- 2.2 kg (P < 0.0

37 ly assigned to receive 25 mg of fluphenazine decanoate intramuscularly either every 2 weeks or every

38 st that the 200-mg/month dose of haloperidol decanoate is associated with the lowest rate of symptoma

39 succinate, and lower concentrations of ethyl decanoate, octanoic and decanoic acids.

40 e incorporated laurate 3-8 times faster than decanoate or myristate, respectively.

41 s were treated for 36 weeks with haloperidol decanoate or vehicle and then withdrawn for an additiona

42 Trihexyl(tetradecyl)phosphonium decanoate phosphonium ionic liquid (IL) was applied for

43 Previous strategies with decanoate preparations have been based on the use of low

44 mewhat activates transcription of rob, while decanoate represses it a bit.

45 d with sodium N-[10-(2-hydroxybenzoyl)amino] decanoate (SNAD) for the treatment of induced venous thr

46 it functions with fatty acids (octanoate and decanoate) that cannot be used by wild-type E. coli stra

47 f 3 medication strategies using fluphenazine decanoate under double-blind conditions: continuous mode

48 ases in serum prolactin, whereas haloperidol decanoate was associated with more akathisia.

49 Methyl decanoate was not an agonist at GPR84.

50 Ethyl decanoate was the compound most influenced by these fung